SAN DIEGO, July 24, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing ...
CEO Douglas Palladini stated that "our business transformation has accelerated as core tenets of new strategies take hold," noting strong engagement from young Gen Z families and emphasizing the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback